Literature DB >> 8550608

Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA.

A K Bosserhoff1, R Hein, U Bogdahn, R Buettner.   

Abstract

We have recently described the isolation of a novel protein, MIA, which is secreted from malignant melanoma cells and elicits growth inhibition on melanoma cells in vitro (Blesch, A., Bosserhoff, A. K., Apfel, R., Behl, C., Hessdörfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Schlingensiepen, H., Buettner, R., and Bogdahn, U. (1994) Cancer Res. 54, 5695-5701). Here, we report the structure of the human MIA gene locus, describe its expression pattern in melanocytic tumors in vivo, and provide an initial characterization of the MIA promoter. The MIA gene is encoded by four exons, and the mRNA initiation site was identified 70 base pairs upstream from the translation start codon. MIA mRNA expression in vivo correlated with progressive malignancy of melanocytic lesions and was inducible in other cells by phorbol esters. To investigate mechanisms mediating this melanoma-associated expression pattern, we analyzed the promoter activity of the 1.3-kilobase genomic sequences located 5'-upstream of the MIA gene. The MIA promoter conferred high levels of gene activation specifically in human and murine melanoma cells, and its activity was further enhanced by treatment with phorbol esters. Site-directed mutation of an NF-kB site within the MIA promoter did reduce the basal promoter activity in melanoma cells but did not change significantly enhancement by phorbol esters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550608     DOI: 10.1074/jbc.271.1.490

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

2.  Evaluation of multiple serum markers in advanced melanoma.

Authors:  Angel Díaz-Lagares; Estíbaliz Alegre; Ainhoa Arroyo; María González-Cao; Maria E Zudaire; Santiago Viteri; Salvador Martín-Algarra; Alvaro González
Journal:  Tumour Biol       Date:  2011-08-20

3.  Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.

Authors:  Ina Poser; Michaela Golob; Reinhard Buettner; Anja K Bosserhoff
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.

Authors:  J C Lougheed; J M Holton; T Alber; J F Bazan; T M Handel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

5.  Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.

Authors:  Markus Moser; Anja-Katrin Bosserhoff; Ernst B Hunziker; Linda Sandell; Reinhard Fässler; Reinhard Buettner
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

6.  Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.

Authors:  King Tuo Yip; Xueyin Zhong; Nadia Seibel; Oliver Arnolds; Miriam Schöpel; Raphael Stoll
Journal:  Biointerphases       Date:  2017-05-31       Impact factor: 2.456

7.  Melanoma biomarkers: Vox clamantis in deserto (Review).

Authors:  Mays Al-Shaer; Divya Gollapudi; Chris Papageorgio
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

Review 8.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

9.  Inhibition of TNF-alpha induced cell death in human umbilical vein endothelial cells and Jurkat cells by protocatechuic acid.

Authors:  J Zhou-Stache; R Buettner; G Artmann; C Mittermayer; A K Bosserhoff
Journal:  Med Biol Eng Comput       Date:  2002-11       Impact factor: 2.602

Review 10.  Biomarkers in melanoma.

Authors:  H Gogas; A M M Eggermont; A Hauschild; P Hersey; P Mohr; D Schadendorf; A Spatz; R Dummer
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.